Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Kuwait KWF

Sokouk Holding Company K.S.C.P. (SOKOUK.KW)

Compare

60.00

+0.30

+(0.50%)

At close: 12:49:27 PM GMT+3

Chinese tech stock Hesai jumps 50% on Mercedes-Benz contract

Hesai Group (HSAI) shares surge after reports that Mercedes-Benz (MBGAF) will equip its upcoming smart driving cars with the Chinese lidar developer's technology, according to reports from Reuters. Julie Hyman and Josh Lipton take a closer look at the monumental stock move. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Naomi Buchanan.

Yahoo Finance Video 13 hours ago

MBGAF

MBGYY

HSAI
Kohl's stock plummets as sales drop, guidance widely misses estimates amid turnaround efforts

The department store is attempting another turnaround.

Yahoo Finance 18 hours ago

KSS

M
Puma Shares Fall Most on Record After Disappointing Guidance

(Bloomberg) -- Puma SE shares plunged the most on record after the sneaker maker disappointed investors with softer-than-expected results and forecast another year of slow growth.Most Read from BloombergNYC Congestion Pricing Toll Gains Support Among City ResidentsTrump DEI Purge Hits Affordable Housing GroupsElectric Construction Equipment Promises a Quiet RevolutionWhere New York City's Zoning Reform Will Add HousingOpen Philanthropy Launches $120 Million Fund To Support YIMBY ReformsThe stock

Bloomberg 24 minutes ago

PUMSY
These Stocks Are Moving the Most Today: Nucor, Alcoa, Intel, Tesla, Super Micro, Stitch Fix, Adobe, and More

Shares of steel makers and aluminum companies rise slightly as President Trump’s 25% tariffs on steel and aluminum go into effect, Tesla stock rises for a second day, and Super Micro edges higher after closing Tuesday with a gain 11%.

Barrons.com 39 minutes ago

ADBE

TSLA

SMCI
Stocks to Watch Wednesday: Intel, Tesla, TSMC, Rheinmetall

↗️ Intel (INTC): Reuters reported Taiwan's TSMC (TSM) has approached Nvidia (NVDA) and other U.S. chip companies about taking stakes in a joint venture that would operate Intel's factories. Shares in Intel jumped 7% in premarket trading.

The Wall Street Journal 52 minutes ago

TSM

TSMWF

RNMBF
Market Chatter: Taiwan Semiconductor Pitched Intel Foundry JV to Nvidia, Other US Chip Companies

Taiwan Semiconductor Manufacturing (TSM) has pitched US companies Nvidia (NVDA), Advanced Micro Devi

PREMIUM
MT Newswires 53 minutes ago

INTC

TSM

NVDA
Nvidia Stock Rises. Why More Volatility Is Coming.

Don't expect the chip maker's shares to stop swinging about anytime soon, as tariffs unnerve markets.

Barrons.com 59 minutes ago

NVDA

AMD

TSM
3 Growth Stocks That Could Help Make You a Fortune

The Trade Desk, Supermicro, and Palo Alto Networks all have plenty of room to grow.

Motley Fool 1 hour ago

PANW

TTD

SMCI
Rheinmetall Annual Sales Soar to Record $10.65 Billion, But Miss Target

While 2024 sales grew 35%, boosted by increased demand, there was a dip in sales at its power systems and trade divisions at the start of of the year.

The Wall Street Journal 2 hours ago

RNMBF

RNMBY
Rheinmetall expects strong 2025 sales in Europe's 'era of rearmament'

BERLIN (Reuters) -Rheinmetall, a major beneficiary of Europe's renewed push to invest in defence, said on Wednesday it expects significant sales growth in 2025 and promised to update guidance after recent geopolitical developments are taken into account. The German defence company expects sales to grow by 25% to 30% in 2025 as a result of the Russian invasion of Ukraine and the decoupling of the United States from Europe, it said. At the same time, Europe's top ammunition maker anticipates an improvement in the operating result and an operating margin of around 15.5%, slightly above the 2024 level of 15.2%.

Reuters 2 hours ago

RNMBY
Zara Parent Inditex Says Expansion Plan on Track Amid Fierce Competition in Fast Fashion

The owner of fashion brand Zara said store and online sales rose 4% at constant currency compared with the prior-year period.

The Wall Street Journal 3 hours ago

IDEXF

IDEXY
EU Hits Back as U.S. Steel and Aluminum Tariffs Take Effect

The 25% global levy was imposed by the Trump administration after the U.S. and Canada backed away from additional measures. The European Union responded with retaliatory tariffs.

The Wall Street Journal 3 hours ago

X
Kohl's Corp (KSS) Q4 2024 Earnings Call Highlights: Navigating Sales Declines and Strategic ...

Kohl's Corp (KSS) faces challenges with declining sales but remains focused on strategic brand and omnichannel improvements to drive future growth.

GuruFocus.com 3 hours ago

KSS
Hesai Group (HSAI) Q4 2024 Earnings Call Highlights: Record Lidar Shipments and Strong ...

Hesai Group (HSAI) reports robust growth in 2024 with over 500,000 Lidar units shipped and projects significant expansion in 2025.

GuruFocus.com 3 hours ago

HSAI
Roche Agrees to Develop Weight-Loss Therapy With Zealand Pharma

The companies agreed to share profits for the therapy equally in the U.S. and Europe, but Roche will have exclusive rights to commercialization in the rest of the world.

The Wall Street Journal 3 hours ago

RHHBF

RHHBY

RHHVF
Zara owner Inditex shares slide after slower start to first quarter

Zara owner Inditex on Wednesday reported a slower start to its first quarter starting February 1, raising questions around its ability to keep building on rapid recent growth and sending its shares down more than 8% in early trading. Strong sales from Zara, which has been gaining market share from rivals such as H&M, have led to a doubling of Inditex's share price over the past three years. Inditex sales were up just 4% in currency-neutral terms over the February 1 to March 10 period, compared to 11% growth a year ago.

Reuters 3 hours ago

ITX.MC
Roche secures Zealand obesity drug candidate for up to $5.3 billion

ZURICH (Reuters) -Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, as the Swiss drugmaker seeks to boost its prospects in the booming weight-loss market. The agreement covering Zealand's compound petrelintide, signals renewed efforts by Roche to catch up with obesity market leaders Novo Nordisk and Eli Lilly. Under the accord, Zealand will receive $1.65 billion upfront with the possibility of milestone payments taking the total sum to $5.3 billion, depending mainly on late-stage trials and sales development, Roche said.

Reuters 3 hours ago

ROG.SW

ZEAL.CO
The most popular stocks for investors in February

February proved to be another eventful month for investors, as escalating trade tensions and geopolitical risks sparked further volatility in markets.

Yahoo Finance UK 4 hours ago

GBPUSD=X

USD=X

GBP=X
Roche enters into an exclusive collaboration & licensing agreement with Zealand Pharma to co-develop and co-commercialise petrelintide as a potential foundational therapy for people with overweight and obesity

Agreement allows for a range of potentially best-in-class therapy options as monotherapy and fixed dose combination with Roche`s lead incretin asset CT 388Collaboration will complement Roche's portfolio in the field of cardiovascular, renal, and metabolic (CVRM) diseasesObesity is a heterogeneous disease with over 200 related comorbidities, including cardiovascular and metabolic diseases, and is expected to impact over 4 billion people globally by 2035 Basel, 12 March 2025 - Roche (SIX: RO, ROG;

GlobeNewswire 4 hours ago

RHHBF

RHHBY

RHHVF
Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesity

Company announcement – No. 4 / 2025 Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesity The companies will co-develop and co-commercialize petrelintide monotherapy and potential combination products, including petrelintide/CT-388, in the U.S. and EuropeZealand Pharma will receive upfront cash payments of USD 1.65 billion, including USD 1.4 billion due at closing

GlobeNewswire 4 hours ago

ZLDPF

Performance Overview

Return	SOKOUK.KW	MSCI WORLD
YTD	+17.88%	-2.47%
1-Year	+15.38%	+7.72%
3-Year	+118.18%	+27.72%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Sokouk Holding Company K.S.C.P. (SOKOUK.KW)

Related News

Chinese tech stock Hesai jumps 50% on Mercedes-Benz contract

Kohl's stock plummets as sales drop, guidance widely misses estimates amid turnaround efforts

Puma Shares Fall Most on Record After Disappointing Guidance

These Stocks Are Moving the Most Today: Nucor, Alcoa, Intel, Tesla, Super Micro, Stitch Fix, Adobe, and More

Stocks to Watch Wednesday: Intel, Tesla, TSMC, Rheinmetall

Market Chatter: Taiwan Semiconductor Pitched Intel Foundry JV to Nvidia, Other US Chip Companies

Nvidia Stock Rises. Why More Volatility Is Coming.

3 Growth Stocks That Could Help Make You a Fortune

Rheinmetall Annual Sales Soar to Record $10.65 Billion, But Miss Target

Rheinmetall expects strong 2025 sales in Europe's 'era of rearmament'

Zara Parent Inditex Says Expansion Plan on Track Amid Fierce Competition in Fast Fashion

EU Hits Back as U.S. Steel and Aluminum Tariffs Take Effect

Kohl's Corp (KSS) Q4 2024 Earnings Call Highlights: Navigating Sales Declines and Strategic ...

Hesai Group (HSAI) Q4 2024 Earnings Call Highlights: Record Lidar Shipments and Strong ...

Roche Agrees to Develop Weight-Loss Therapy With Zealand Pharma

Zara owner Inditex shares slide after slower start to first quarter

Roche secures Zealand obesity drug candidate for up to $5.3 billion

The most popular stocks for investors in February

Roche enters into an exclusive collaboration & licensing agreement with Zealand Pharma to co-develop and co-commercialise petrelintide as a potential foundational therapy for people with overweight and obesity

Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesity

Performance Overview